Synapse - Works

Results (5599)

Nazartinib (EGF816) in patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results

Meeting Abstract

Tan, D. S. W.; Leighl, N. B.; Yang, J. C. H.; Riely, G. J.; Sequist, L. V.; Toyozawa, R.; Wolf, J.; Felip, E.; Kim, S. W.; Aix, S. P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Results of a randomized phase II/III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus docetaxel for high-grade soft tissue sarcomas: Japan Clinical Oncology Group study JCOG1306

Meeting Abstract

Tanaka, K.; Machida, R.; Kawai, A.; Nakayama, R.; Tsukushi, S.; Asanuma, K.; Matsumoto, Y.; Hiraga, H.; Hiraoka, K.; Watanuki, M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial

Meeting Abstract

Subbiah, V.; Gainor, J. F.; Oxnard, G. R.; Tan, D. S. W.; Owen, D. H.; Cho, B. C.; Loong, H. H. F.; McCoach, C. E.; Weiss, J.; Kim, Y.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax

Meeting Abstract

Soumerai, J. D.; Mato, A. R.; Carter, J.; Dogan, A.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; Abramson, J. S.; Batlevi, C. L.; Joffe, E.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

CheckMate 067: Long-term outcomes in patients with mucosal melanoma

Meeting Abstract

Shoushtari, A. N.; Wagstaff, J.; Ascierto, P. A.; Butler, M. O.; Lao, C. D.; Marquez-Rodas, I.; Chiarion-Sileni, V.; Dummer, R.; Ferrucci, P. F.; Lorigan, P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Effect of adding ublituximab to ibrutinib on PFS, ORR, and MRD negativity in previously treated high-risk chronic lymphocytic leukemia: Final results of the GENUINE phase III study

Meeting Abstract

Sharman, J. P.; Brander, D. M.; Mato, A. R.; Ghosh, N.; Schuster, S. J.; Kambhampati, S.; Burke, J. M.; Lansigan, F.; Schreeder, M. T.; Lunin, S. D.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01

Meeting Abstract

Smit, E. F.; Nakagawa, K.; Nagasaka, M.; Felip, E.; Goto, Y.; Li, B. T.; Pacheco, J. M.; Murakami, H.; Barlesi, F.; Saltos, A. N.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Correlation between overall response rate and progression-free survival/overall survival in comparative trials involving targeted therapies in molecularly enriched populations

Meeting Abstract

Solomon, B. J.; Loong, H. H. F.; Summers, Y. J.; Thomas, Z. M.; French, P. P.; Lin, B. K.; Sashegyi, A.; Wolf, J.; Yang, J. C. H.; Drilon, A. E.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Telemedicine visits reduce time to biopsy, travel time and costs for interventional radiology patients

Meeting Abstract

Shah, S.; Erinjeri, J.; Guan, Q. X.; Otto, C.; Solomon, S. B.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Association of geriatric comanagement with reduction in adverse surgical outcomes among patients 75 or older with cancer with prolonged hospital stay

Meeting Abstract

Shahrokni, A.; Kim, S. J.; Alexander, K.; Sun, S. W.; McMillan, S.; Downey, R. J.; Korc-Grodzicki, B.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save